表紙
市場調査レポート

in-situハイブリダイゼーション (ISH) の世界市場分析・予測 2019年:DNA・RNA・癌診断・細胞学・免疫学

In situ Hybridization Market by Type (DNA, RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019

発行 MarketsandMarkets 商品コード 338073
出版日 ページ情報 英文 182 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
in-situハイブリダイゼーション (ISH) の世界市場分析・予測 2019年:DNA・RNA・癌診断・細胞学・免疫学 In situ Hybridization Market by Type (DNA, RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019
出版日: 2015年08月13日 ページ情報: 英文 182 Pages
概要

世界のin-situハイブリダイゼーション (ISH) 市場規模は2014年に5億5,440万米ドルとなり、2014年から2019年にかけては4.2%のCAGRで推移すると見られ、2019年までに6億8,100万米ドルに達すると推計されています。

当レポートでは、世界のin-situハイブリダイゼーション (ISH) 市場ついて調査し、市場概要、市場への各種影響因子および市場機会の分析、市場全体およびタイプ・アプリケーション・エンドユーザー・地域別の市場動向と市場成長予測、競合環境、および主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 市場ダイナミクス

第5章 in-situハイブリダイゼーション (ISH) 市場:タイプ別

第6章 in-situハイブリダイゼーション (ISH) 市場:アプリケーション別

第7章 in-situハイブリダイゼーション (ISH) 市場:エンドユーザー別

第8章 in-situハイブリダイゼーション (ISH) 市場:地域別

第9章 競合情勢

第10章 企業プロファイル

  • ABBOTT
  • BIOGENEX
  • BIOSB
  • F. HOFFMANN-LA ROCHE LTD
  • SIGMA-ALDRICH CO. LLC.
  • ADVANCED CELL DIAGNOSTICS
  • AFFYMETRIX, INC.
  • EXIQON A/S
  • AGILENT TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC, INC.

第11章 付録

図表

目次
Product Code: BT 3649

In-situ hybridization (ISH) is a powerful technique used for focusing on specific nucleic acid targets within fixed tissues and cells, to obtain temporal and spatial information about gene expression. The in-situ hybridization technique is divided into two types, namely DNA and RNA. This is because, normally ISH requires isolation of DNA or RNA which is done by separating it on a gel, blotting it onto nitrocellulose, and probing it with a complementary sequence.

The global in-situ hybridization market was valued at $554.4 million 2014, and is estimated to reach $681.0 million by 2019, at a CAGR of 4.2% from 2014 to 2019.

The global in-situ hybridization market is primarily driven by the increasing prevalence of cancer disease, growing usage of personalized medicines for its treatment, and rising number of initiatives undertaken by the government, such as create awareness about cancer and providing funding to support related researches.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis.

Some of the companies profiled in this report are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Agilent Technologies, Inc. (U.S.).

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the global in-situ hybridization market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to analyze the market, which in turn will help the firms in achieving greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global in-situ hybridization market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of product approvals, pipeline products, and product recalls.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for in-situ hybridization across geographies, exploit new distribution channels, new clientele base, and different pricing policies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global in-situ hybridization market. Detailed description regarding the related and unrelated diversification pertaining to this market.
  • Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies operational in the global in-situ hybridization market.

TABLE OF CONTENTS

1. INTRODUCTION

2. EXECUTIVE SUMMARY

3. MARKET OVERVIEW

4. MARKET DYNAMICS

5. IN-SITU HYBRIDIZATION MARKET, BY TYPE

6. IN-SITU HYBRIDIZATION MARKET, BY APPLICATION

7. IN-SITU HYBRIDIZATION MARKET, BY END USER

8. IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY

9. COMPETITIVE LANDSCAPE

10. COMPANY PROFILES

  • 10.1. ABBOTT
  • 10.2. BIOGENEX
  • 10.3. BIOSB
  • 10.4. F. HOFFMANN-LA ROCHE LTD
  • 10.5. SIGMA-ALDRICH CO. LLC.
  • 10.6. ADVANCED CELL DIAGNOSTICS
  • 10.7. AFFYMETRIX, INC.
  • 10.8. EXIQON A/S
  • 10.9. AGILENT TECHNOLOGIES
  • 10.10. THERMO FISHER SCIENTIFIC, INC.

11. APPENDIX

LIST OF TABLES

  • TABLE 1: In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
  • TABLE 2: DNA In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 3: DNA Fluorescent In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 4: DNA Chromogenic In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 5: RNA In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 6: RNA Fluorescent In-Situ Hybridization (FISH) Market, By Geography, 2012-2019 (USD MN)
  • TABLE 7: RNA Chromogenic In-Situ Hybridization (CISH) Market, By Geography, 2012-2019 (USD MN)
  • TABLE 8: In-Situ Hybridization Market, By Application, 2012-2019 (USD MN)
  • TABLE 9: Cancer Diagnostics Market, By Geography, 2012-2019 (USD MN)
  • TABLE 10: Cytology Market, By Geography, 2012-2019 (USD MN)
  • TABLE 11: Neuroscience Market, By Geography, 2012-2019 (USD MN)
  • TABLE 12: Immunology Market, By Geography, 2012-2019 (USD MN)
  • TABLE 13: Other Applications Market, By Geography, 2012-2019 (USD MN)
  • TABLE 14: Market, By End User, 2012 - 2019 (USD MN)
  • TABLE 15: Hospital Market, By Geography, 2012-2019 (USD MN)
  • TABLE 16: Pharma & Biotech Companies Market, By Geography, 2012-2019 (USD MN)
  • TABLE 17: Research Labs Market, By Geography, 2012-2019 (USD MN)
  • TABLE 18: Cros Market, By Geography, 2012-2019 (USD MN)
  • TABLE 19: Other End User Market, By Geography, 2012-2019 (USD MN)
  • TABLE 20: In-Situ Hybridization Market, By Geography, 2012-2019 (USD MN)
  • TABLE 21: North America In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
  • TABLE 22: North America DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 23: North America RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 24: North America In-Situ Hybridization Market, By Application, 2012-2019 (USD MN)
  • TABLE 25: North America In-Situ Hybridization Market, By End User, 2012-2019 (USD MN)
  • TABLE 26: Europe In-Situ Hybridization Market, By Type, 2012-2019 (USD MN)
  • TABLE 27: Europe DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 28: Europe RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 29: Europe: Market, By Application, 2012-2019 (USD MN)
  • TABLE 30: Europe: Market, By End User, 2012- 2019 (USD MN)
  • TABLE 31: APAC: Market, By Type, 2012- 2019 (USD MN)
  • TABLE 32: APAC DNA In-Situ Hybridization Market, By Technique, 2012- 2019 (USD MN)
  • TABLE 33: APAC RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 34: APAC: Market, By Application, 2012-2019 (USD MN)
  • TABLE 35: APAC: Market, By End User, 2012-2019 (USD MN)
  • TABLE 36: RoW: Market, By Type, 2012- 2019 (USD MN)
  • TABLE 37: RoW DNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 38: RoW RNA In-Situ Hybridization Market, By Technique, 2012-2019 (USD MN)
  • TABLE 39: RoW: Market, By Application, 2012-2019 (USD MN)
  • TABLE 40: RoW: Market, By End User, 2012- 2019 (USD MN)

LIST OF FIGURES

  • FIGURE 1: Market Size, 2014 & 2019
  • FIGURE 2: Market Size, 2014 & 2019
  • FIGURE 3: Market Size, 2014 & 2019
  • FIGURE 4: Market Size, 2014 & 2019 (USD MN)
  • FIGURE 5: Market, By Type, 2014 & 2019 (USD MN)
  • FIGURE 6: DNA In-Situ Hybridization Market, By Technique, 2014 & 2019 (USD MN)
  • FIGURE 7: RNA In-Situ Hybridization Market, By Technique, 2014 & 2019 (USD MN)
  • FIGURE 8: Market, By Application, 2014 & 2019 (USD MN)
  • FIGURE 9: Market, By End-User, 2014 & 2019 (USD MN)
  • FIGURE 10: In-Situ Hybridization Market, By Type, 2014 & 2019 (USD MN)
  • FIGURE 11: DNA In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 12: DNA Fluorescent In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 13: DNA Chromogenic In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 14: RNA In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 15: RNA Fluorescent In-Situ Hybridization (FISH) Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 16: RNA Chromogenic In-Situ Hybridization (CISH) Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 17: Market, By Application, 2014 & 2019 (USD MN)
  • FIGURE 18: Market, By Application, 2014 & 2019 (USD MN)
  • FIGURE 19: Cancer Diagnostics Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 20: Cytology Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 21: Neuroscience Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 22: Immunology Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 23: Other Application Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 24: Market, By End User, 2012 - 2019 (USD MN)
  • FIGURE 25: End-User Market, By Geography, 2014 & 2019 (USD MN)
  • FIGURE 26: Hospitals Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 27: Pharma & Biotech Companies Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 28: Research Labs Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 29: Cros Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 30: Others Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 31: In-Situ Hybridization Market, By Geography, 2012 - 2019 (USD MN)
  • FIGURE 32: North America: Market, 2014 & 2019 (%)
  • FIGURE 33: Europe: Market, 2014 & 2019 (%)
  • FIGURE 34: APAC: Market, 2014 & 2019 (%)
  • FIGURE 35: RoW: Market, 2014 & 2019 (%)
Back to Top